Skip links

Business

Strongpoint Partners

Strongpoint Partners Announces Partnership with Actuaries Unlimited

Strongpoint Partners expands its West Coast presence with the addition of Actuaries Unlimited (“AUI”), the 13th distinct retirement services brand to join its family of full-service retirement and actuarial solutions firms  Strongpoint Partners (“Strongpoint”), a tech-enabled retirement services platform serving small- to mid-sized businesses with integrated

DelveInsight

Radioligand Therapies Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Curium, Eli Lilly, Point biopharma, Fusion, Astrazeneca

The Key Radioligand Therapies Companies in the market include – Curium, Eli Lilly, Point biopharma, Fusion, Astrazeneca, and others. DelveInsight’s “Radioligand Therapies Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Radioligand Therapies, historical and forecasted epidemiology as well as the Radioligand Therapies